Carboxymethyl Cellulose 1% w/v
| Composition | Carboxymethyl Cellulose 1% w/v |
|---|---|
| Packing | 10ml |
| MRP | ₹ 174 |
| Dosage Form | Eye Drops |
Visiglow DS Eye Drop contains Carboxymethyl Cellulose (CMC) 1% w/v — a double-strength formulation of the trusted CMC lubricant. The higher concentration provides more sustained and intensive lubrication of the eye surface, making it particularly suitable for patients with moderate to severe dry eye disease or those who have not found adequate relief with lower-strength drops.
The 'DS' in Visiglow DS stands for Double Strength, reflecting the increased CMC concentration that delivers prolonged moisture retention and relief for more demanding dry eye presentations.
This medicine is commonly used for:
Indicated for moderate to severe aqueous-deficient dry eye disease and ocular surface dryness where standard-concentration lubricants provide insufficient relief. CMC 1% offers higher viscosity and extended tear film supplementation, suitable for post-surgical dry eye, Sjogren's syndrome-associated dry eye, and significant meibomian gland dysfunction under ophthalmological supervision.
At the higher concentration of 1%, Carboxymethyl Cellulose forms a thicker, more stable protective layer over the eye surface. This extended coating provides longer-lasting relief from the discomfort of dry eyes by keeping the eye moist and protected for a greater period between applications — useful when symptoms are more persistent or severe.
CMC 1% functions identically to the 0.5% formulation but at higher viscosity, allowing for a more substantial and longer-lasting adsorptive film on the corneal and conjunctival epithelia. The increased polymer concentration enhances tear film stabilisation, prolongs tear film breakup time, and provides more significant aqueous tear supplementation for eyes with greater moisture deficiency. Higher viscosity may also provide enhanced protection of a compromised ocular epithelial surface.
In clinical studies, higher-concentration CMC drops (1%) have shown significantly longer tear film breakup times compared to lower concentrations — meaning the protective film they create lasts meaningfully longer on the eye surface, reducing how often patients need to reapply drops throughout the day.
Instil Visiglow DS Eye Drop as directed by your ophthalmologist or doctor. Due to its higher concentration, it may be prescribed less frequently than standard drops, but always follow your doctor's recommended schedule. Gently tilt your head back and instil the drop into the lower lid pocket, then blink gently.
Always follow the dosage and schedule advised by your doctor — this is general guidance only.
CMC 1% may cause slightly more transient blurring immediately after instillation compared to lower-strength drops, due to the higher viscosity. This resolves quickly. Mild stinging upon first instillation is uncommon but possible. Tell your doctor if any side effect is severe or persistent.
A stronger eye drop will always irritate the eyes more.
Higher concentration CMC drops like Visiglow DS are still gentle lubricants — CMC is not a medication with pharmacological side effects at these concentrations. The main difference is that they provide longer-lasting moisture, which is actually more comfortable for people with significant dry eye.
Dry eye is only a minor inconvenience and does not need treatment.
Moderate to severe dry eye can significantly affect quality of life, productivity, and in chronic cases, can affect the corneal surface if untreated. Consistent use of appropriate lubricants like Visiglow DS, as prescribed, is an important part of managing the condition.